Hepion Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$3.71 | -$3.71 | -$3.71 |
| Q2 2024 | 1 | -$1.90 | -$1.90 | -$1.90 |
| Q3 2024 | 1 | -$1.97 | -$1.97 | -$1.97 |
Hepion Pharmaceuticals, Inc. Earnings Date And Information
Hepion Pharmaceuticals, Inc. last posted its earnings results on Monday, April 1st, 2024. The company reported $-2.42306 earnings per share for the quarter, topping analysts' consensus estimates of $-2.63 by $0.20694. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Hepion Pharmaceuticals, Inc. has generated $-12 earnings per share over the last year ($-12.32 diluted earnings per share) and currently has a price-to-earnings ratio of -0.13. Hepion Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 18th, 2024 based on prior year's report dates.
Hepion Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/13/2024 | Q2 2024 | -$0.68 | $0 | $0 | ||
| 05/21/2024 | Q1 2024 | -$0.56 | $0 | |||
| 06/24/2024 | Q4 2023 | -$2.42 | $109,730 | |||
| 11/20/2023 | Q3 2023 | -$2.68 | -$2.74 | -0.06 | $0 | |
| 08/14/2023 | Q2 2023 | -$3.32 | -$3.68 | -0.36 | $0 | |
| 05/12/2023 | Q1 2023 | -$3.60 | -$3.48 | 0.12 | $0 | |
| 04/10/2023 | Q4 2022 | -$0.13 | -$1.79 | -1.66 | $0 | |
| 11/14/2022 | Q3 2022 | -$0.17 | -$2.24 | -2.07 | $0 | |
| 08/15/2022 | Q2 2022 | -$0.12 | -$5.22 | -5.1 | $0 | |
| 05/16/2022 | Q1 2022 | -$0.13 | -$1.82 | -1.69 | $0 | |
| 04/08/2022 | Q4 2021 | -$0.12 | -$2.55 | -2.43 | $0 | |
| 11/15/2021 | Q3 2021 | -$2.43 | $0 | |||
| 08/16/2021 | Q2 2021 | -$0.19 | -$2.01 | -1.82 | $0 | |
| 05/14/2021 | Q1 2021 | -$0.20 | -$2.32 | -2.12 | $0 | |
| 03/31/2021 | Q4 2020 | -$0.20 | -$5.89 | -5.69 | $0 | |
| 11/16/2020 | Q3 2020 | -$10.20 | -$13.81 | -3.61 | $0 | |
| 08/12/2020 | Q2 2020 | -$10.00 | -$11.63 | -1.63 | $0 | |
| 06/29/2020 | Q1 2020 | -$0.25 | -$19.45 | -19.2 | $0 | |
| 05/14/2020 | Q4 2019 | -$10.64 | $0 | |||
| 11/14/2019 | Q3 2019 | -$12.80 | -$10.54 | 2.26 | $1.16 B | $0 |
Hepion Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Hepion Pharmaceuticals, Inc.'s earnings date?
Hepion Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 18th, 2024 based off last year's report dates.
-
Did Hepion Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, Hepion Pharmaceuticals, Inc. (:HEPA) reported $-2.42306 earnings per share (EPS) to beat the analysts' consensus estimate of $-2.63 by $0.20694.
-
How can I listen to Hepion Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Hepion Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Hepion Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Hepion Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much profit does Hepion Pharmaceuticals, Inc. generate each year?
Hepion Pharmaceuticals, Inc. (:HEPA) has a recorded net income of $0. Hepion Pharmaceuticals, Inc. has generated $-12.32 earnings per share over the last four quarters.
-
What is Hepion Pharmaceuticals, Inc.'s price-to-earnings ratio?
Hepion Pharmaceuticals, Inc. (:HEPA) has a price-to-earnings ratio of -0.13 and price/earnings-to-growth ratio is -0.
